Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Relationship between plasma circulating cell-free DNA concentration and treatment outcomes including prognosis in patients with advanced non-small cell lung cancer

Fig. 3

Kaplan-Meier analysis of the BT1 cfDNA/NLR subgroup. 1: “Low grade” ((BT1 cfDNA < 15ng/mL and NLR < 2.98); 2: “Low-intermediate” (BT1 cfDNA < 15ng/mL and NLR ≥ 2.98); 3: " High Intermediate” (BT1 cfDNA ≥ 15ng/mL and NLR < 2.98); 4: “High Grade” (BT1 cfDNA ≥ 15ng/mL and NLR ≥ 2.98)

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us